Pamidronate to reduce bone pain in normocalcaemic patient with disseminated prostatic carcinoma. [electronic resource]
- Lancet (London, England) May 1989
- 1021-2 p. digital
Publication Type: Case Reports; Letter
0140-6736
10.1016/s0140-6736(89)92665-2 doi
Adenocarcinoma--secondary Calcium--blood Diphosphonates--therapeutic use Humans Male Middle Aged Pain Measurement Pain, Intractable--drug therapy Pamidronate Prostatic Neoplasms--pathology Spinal Neoplasms--secondary